Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-1996 | 10-1995 | 10-1994 | 10-1993 | 10-1992 | |
| Gross Profit | 52,225 | 51,684 | 35,237 | 23,396 | 17,139 |
| Operating Expenses | 5,455 | 5,133 | 4,091 | 2,838 | 2,719 |
| Operating Income | -5,455 | -5,133 | -4,091 | -2,838 | -2,719 |
| Pre-tax Income | -5,455 | -5,133 | -4,091 | -2,838 | -2,719 |
| Net Income Continuous | -5,455 | -5,133 | -3,853 | -2,838 | -2,719 |
| Net Income | $-5,455 | $-5,133 | $-3,853 | $-2,838 | $-2,719 |
| EBITDA(a) | $-724 | $-1,613 | $-1,008 | $-779 | $-894 |